Profile number 107229

The hearing & vision diagnostic systems of the future

29/11/2023 Date added

Located in


Also interesting for this region (s)

  • Noord-Nederland
  • Oost-Nederland
  • West-Nederland
  • Zuid-Nederland

General information



Type of company


Legal entity

Private limited company

Type of transaction

To be determined

Life phase enterprise


Employees in FTE

5 - 10

Type of buyer


Financial information

Turnover last financial year

€ 250.000 - € 500.000

Asking price

€ 500.000 - € 1.000.000

Earnings before taxes

€ 0 - € 100.000

Company history/background
  • The company is a software healthtech venture spun out of the Donders Institute at Radboud University in NL. Using our patented world-class Brain Computer Interface (“BCI”) and Artificial Intelligence (“AI”) technology, we are developing fast, accurate and easy-to-use hearing and vision diagnostic testing which rely solely on patient brain-response not manual response. In 2021, we received a E600k R&D pilot contract with GNResound, 3rd largest hearing aid company globally. We been awarded 2x MIT Partnership Grants, 2x Marie Curie Horizon Grants (UMC Groningen & Radboud), as well as the Eurostar grant for the product- our hearing diagnostic prototype. The product, has successfully undergone 2 early validation tests at Horzentrum Oldenburg – the leading European hearing research facility. 
  • Our core activities include: research and development, software development, product design, management and marketing. 
  • We have 10 FTEs: CEO, R&D engineers, data scientists, neuroscientists, software development, lab manager plus leading audiologists as paid advisors. We have strong partnerships with UMC Utrecht, UMC Radboud, U of Magdeburg and Horzentrum Oldenburg

Company activities
  • Using our patented world-class Brain Computer Interface (“BCI”) and AI technology, we are developing the next generation of hearing and vision diagnostic testing which relies solely on  brain-response. We are able to interpret a patient’s brain response to visual or auditory stimuli at 20x greater speed and higher level of accuracy than the competition. This enables us to create a completely objective diagnostic test that is fast and easy-to-use. 
  • Working together with EEG leading hardware partners, we are finalizing our validated working prototype.The prototype will provide fast accurate hearing diagnostic testing for patients over the ages of 2 years to 100++ which unlike conventional systems, does not require a patient response. The prototype will be certified as a class 2a medical device in the US and Europe by Q4 2025 and launched into the market quickly thereafter. The prototype has undergone external early validation testing at Horzentrum Oldenburg and our first useability pilot at Koraal – a long term care facility. We have been working with the leading audiology specialists to design the final minimum viable product in order to ensure a successful product/market fit. 

Unique selling points
  • The product is unique in that it combines the advantages of the range of currently available hearing test systems without the disadvantages. It has the speed and objectivity of conventional hearing screening (pass/fail) tests, the comprehensiveness of standard hearing diagnostic test plus the objectivity of the current brain response based hearing diagnostic test. However, it does not have the disadvantages: Current screening test are inaccurate and incomplete. Conventional hearing diagnostic tests are inaccurate and time consuming for the hard-to-test population. Current brain response tests are extremely costly, timing consuming and require anaesthesia to render the patient immobile during the test. The productalso contains additional benefits versus conventional testing in that it is an automated system that will not require a highly trained testing administrator. It is lightweight making it easily transportable to long term care homes for disabled or elderly patients and finally it is relaxing for the patient with a large video selection. 
  • Focus on:  Final product development, certification, insurance reimbursability and market launch 

  • Hearing and vision are critical for educational development, social connection and mental health. The WHO estimates that over 1.5b people suffer from hearing impairment with only 23% being treated. Unaddressed hearing impairment cost our society more than $1trillion in excess health care and long-term care costs as well as reduced productivity. As our population ages, these issues will continue to grow. Treatment rates of 23% imply that the hearing aid industry ($10b market) and the hearing diagnostics market ($2.2B) are only serving a fraction of their targeted patient population. 
  • One of the key reasons for low treatment levels is that conventional diagnostic testing systems for hearing and vision are based upon technology over 60 years old which relies on patients responding accurately (>100 button presses!). While these tests are irritating and tiresome for typical patients, they are inadequate to address the needs of the global 1.6b patients in the “hard-to-test” population (children, the disabled and the elderly) who struggle to perform the required responses.
  •  With this system, all segments of population can efficiently diagnosed for treatment    

The hearing & vision diagnostic systems of the future
For sale
250.000 - 500.000
500.000 - 1.000.000
Get in contact Save to favourites

Interested or more information?

You can get in touch with the profile provider free of charge and without obligation. After entering your e-mail address you can express your interest or request more information. The data requested by us is intended solely for making contact and will therefore be treated discretely by the receiving party.

This is how you get in touch:

  • Enter your e-mail address below
  • If it is already known, log in or click on forgot password
  • Then fill in the response form and send it
  • We check your response and send it to the provider
  • The provider will contact you within 7 days
  • Didn't hear anything after 7 days? Let us know

Accompanying text for provider

  • Ask your questions
  • Indicate where your interest comes from
  • Tell something about your background

Available capital

Please note: financing a business acquisition requires a minimum of 25% own contribution.

This data is only intended for establishing contact. The data is checked by us before we send it to the provider. Responses that are incomplete or contain incorrect information will not be forwarded.

Postal code

Please enter your postal code and house number and the address will be filled in automatically.


Make sure you enter the right data, otherwise the owner cannot contact you.

Phone number

If we contact you, we will always do so confidentially. Please be sure to enter the right number.

Mobile phone number

If we contact you, we will always do so confidentially. Please be sure to enter the right number.

After posting this reaction, an account will be created for you automatically. From here you can easily manage these and any subsequent responses. Create a password below. The password must be at least 6 characters long.